Stay updated on Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor internal update. There are no changes to the visible content or functionality presented on the study page.
    Difference
    0.1%
    Check dated 2026-09-01T18:10:39.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a minor update to the page's revision tag rather than a change to study data or content.
    Difference
    0.0%
    Check dated 2026-08-11T15:52:30.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4. This signals a backend/documentation update without changing the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-28T05:10:07.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.3, signifying a small documentation/versioning update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-06T10:57:32.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The revision label on the page has been updated to v3.6.2, replacing the previous v3.6.0. This represents a small backend or formatting update without impacting the study information presented.
    Difference
    0.0%
    Check dated 2026-06-29T09:58:20.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice states the study is no longer looking for participants. The Intervention/Treatment heading formatting was adjusted and the revision label updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-15T06:58:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.